Kato Taigo, Madono Keigo, Saito Jun, Kakuta Yoichi, Tanigawa Go, Yazawa Koji, Hosomi Masahiro, Ito Kiichiro
The Department of Urology, Osaka General Medical Center.
Hinyokika Kiyo. 2008 Feb;54(2):119-22.
We report a case of renal cell carcinoma in which interferon-a therapy was effective in reducing the tumor thrombus extending into the inferior vena cava. A 66-year-old man was referred to our hospital with a complaint of macroscopic hematuria, cough and general fatigue. We made a diagnosis of a left renal cell carcinoma with tumor thrombus by imaging examination. Because his performance status was 3, a radical operation was considered risky. Twenty-two months after the start of interferon-a therapy, the tumor thrombus was markedly reduced in size, and the clinical response was evaluated as partial response by the response criteria for urological cancer treatrment. Because of improvement of the performance status and downsizing of tumor thrombus, we performed radical nephrectomy. Pathological examinations revealed that viable renal cell carcinomas were found in the primary lesion and the tumor thrombus. In some cases, interferon-alpha therapy is useful and safe in the treatment of the tumor thrombus. Furthermore, radical nephrectomy and complete resection of the tumor thrombus prolongs postoperative survival.
我们报告一例肾细胞癌,其中干扰素-α治疗在减少延伸至下腔静脉的肿瘤血栓方面有效。一名66岁男性因肉眼血尿、咳嗽和全身乏力就诊于我院。通过影像学检查,我们诊断为左肾细胞癌伴肿瘤血栓。由于其体能状态为3,根治性手术被认为具有风险。在开始干扰素-α治疗22个月后,肿瘤血栓大小明显减小,根据泌尿生殖系统癌症治疗反应标准,临床反应被评估为部分缓解。由于体能状态改善和肿瘤血栓缩小,我们进行了根治性肾切除术。病理检查显示,在原发灶和肿瘤血栓中均发现存活的肾细胞癌。在某些情况下,干扰素-α治疗在肿瘤血栓治疗中是有用且安全的。此外,根治性肾切除术和肿瘤血栓的完全切除可延长术后生存期。